[HTML][HTML] COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: a multicenter interventional study

S Alsharidah, M Ayed, RM Ameen, F Alhuraish… - … Journal of Infectious …, 2021 - Elsevier
… sampling technique to identify control patients from the COVID-19 national registry. For each
patient who received CCP, we selected the first two patients with the same disease severity …

Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases

J Castillo-Olivares, DA Wells, M Ferrari… - Frontiers in …, 2021 - frontiersin.org
… , severe COVID-19 patients showed statistically … from COVID-19 convalescent patients
and seropositive HCW, but not those from seronegative HCW, neutralised effectively SARS-CoV-2’…

Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals

SE Butler, AR Crowley, H Natarajan, S Xu… - Frontiers in …, 2021 - frontiersin.org
… , other pathogenic CoV strains, and SARS-CoV-2 following infection will contribute … Infection
with SARS-CoV-2 was confirmed by PCR of nasopharyngeal swab for all COVID-19 patients

[HTML][HTML] Distinct early serological signatures track with SARS-CoV-2 survival

C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke… - Immunity, 2020 - cell.com
two cross-sectional sample sets of SARS-CoV-2-infected … that deceased and convalescent
individuals present different … functions for convalescent (left) and deceased (right) patients. For …

Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients

X Wang, X Guo, Q Xin, Y Pan, J Li, Y Chu, Y Feng… - MedRxiv, 2020 - medrxiv.org
… In the study, typical antibody responses to live viral infection were seen induced in all
COVID-19 patients regardless the stage of the disease. Moreover, the immunity levels were …

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis

HR Savage, VS Santos, T Edwards… - PLoS neglected …, 2021 - journals.plos.org
… seen in this review might be explained by some patients having responses confined to
SARS-CoV-2 antigens not identified by the assays used, or mediated through T cells, which are …

[HTML][HTML] The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Q Li, J Wu, J Nie, L Zhang, H Hao, S Liu, C Zhao… - Cell, 2020 - cell.com
… The spike protein of SARS-CoV-2convalescent patients. D614G, along with several variants
containing both D614G and another amino acid change, were significantly more infectious. …

Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2021 - mdpi.com
… , we observed higher SARS-CoV-2 antibody titers in the convalescent individuals aged ≥…
, we observed that the rate of SARS-CoV-2 infection among patients who have received their …

Reactive T cells in convalescent COVID-19 patients with negative SARS-CoV-2 antibody serology

S Steiner, T Schwarz, VM Corman, F Sotzny… - Frontiers in …, 2021 - frontiersin.org
… syndrome coronavirus 2 (SARS-CoV-2). In response to an infection with SARS-CoV-2, …
To date, it remains uncertain whether convalescent SARS-CoV-2 infected patients develop …

[HTML][HTML] The convalescent sera option for containing COVID-19

A Casadevall, L Pirofski - The Journal of clinical …, 2020 - Am Soc Clin Investig
… antibody against the same virus, SARS2-CoV-2, ADE may be … use of convalescent sera in
patients with SARS1 and MERS (… that convalescent serum will prevent SARS-CoV-2 infection